Cargando…
Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections
Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory infection associated with declining lung function, radiological deterioration and significantly increased morbidity and mortality. Patients often have underlying lung conditions, particularly bronchiectasis and COPD. NTM p...
Autores principales: | Chalmers, James D., van Ingen, Jakko, van der Laan, Roald, Herrmann, Jean-Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488898/ https://www.ncbi.nlm.nih.gov/pubmed/34289985 http://dx.doi.org/10.1183/16000617.0010-2021 |
Ejemplares similares
-
Global survey of physician testing practices for nontuberculous mycobacteria
por: Loebinger, Michael R., et al.
Publicado: (2023) -
Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician survey
por: Wagner, Dirk, et al.
Publicado: (2020) -
The epidemiology of nontuberculous mycobacterial pulmonary disease in the Netherlands
por: Schildkraut, Jodie Anne, et al.
Publicado: (2021) -
Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease
por: Rubino, Christopher M., et al.
Publicado: (2021) -
Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease
por: Rubino, Christopher M., et al.
Publicado: (2021)